CHGB and Parkinson disease: Further characterizing the role of chromogranins in neurodegenerative disease, a study investigating their role in Parkinson’s disease (PD) discovered that peptide processing, mediated by CHGB, was compromised, leading to dysregulation of several related proteins and peptides [23].